Conversion of skin tests in cancer patients after a short course of treatment with a new immunostimulating compound
✍ Scribed by Jean-Marie Lang; Cathy Giron; Francis Oberling; Christiane Marchiani; René Zalisz
- Publisher
- Springer-Verlag
- Year
- 1980
- Tongue
- English
- Weight
- 110 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In hepatitis C virus (HCV) genotypes 2 and 3 patients, the high rate of relapse after 12 to 16 weeks of antiviral therapy is the main concern for shortening treatment duration. This study was undertaken to delineate predictors of relapse after short treatment in patients with undetectable HCV RNA at
C 1821 is a purified glycoprotein extract of Klebsiella pneumoniae serotype 2 with immunomodulating properties in animals (in vivo and in vitro) and in humans (in vitro). The compound is devoid of any apparent toxicity when given orally. The aim of the present work was to evaluate the effects of a s